These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3115225)

  • 1. Synaptophysin. A new and promising pan-neuroendocrine marker.
    Gould VE
    Arch Pathol Lab Med; 1987 Sep; 111(9):791-4. PubMed ID: 3115225
    [No Abstract]   [Full Text] [Related]  

  • 2. Synaptophysin expression in neuroendocrine neoplasms as determined by immunocytochemistry.
    Gould VE; Wiedenmann B; Lee I; Schwechheimer K; Dockhorn-Dworniczak B; Radosevich JA; Moll R; Franke WW
    Am J Pathol; 1987 Feb; 126(2):243-57. PubMed ID: 3103452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogranins and neuroendocrine secretion.
    Angeletti RH
    Lab Invest; 1986 Oct; 55(4):387-90. PubMed ID: 3762064
    [No Abstract]   [Full Text] [Related]  

  • 4. Synaptophysin: a novel marker for neurons, certain neuroendocrine cells, and their neoplasms.
    Gould VE; Lee I; Wiedenmann B; Moll R; Chejfec G; Franke WW
    Hum Pathol; 1986 Oct; 17(10):979-83. PubMed ID: 3093369
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum.
    Grabowski P; Schönfelder J; Ahnert-Hilger G; Foss HD; Heine B; Schindler I; Stein H; Berger G; Zeitz M; Scherübl H
    Virchows Arch; 2002 Sep; 441(3):256-63. PubMed ID: 12242522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptophysin immunoreactivity and small clear vesicles in neuroendocrine cells and related tumours.
    Buffa R; Rindi G; Sessa F; Gini A; Capella C; Jahn R; Navone F; De Camilli P; Solcia E
    Mol Cell Probes; 1987 Dec; 1(4):367-81. PubMed ID: 3134611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecules of regulated secretion are differentiation markers of neuroendocrine tumors].
    Schmitt-Gräff A; Müller H; Rancso C; Ahnert-Hilger G; John M; Riecken EO; Stein H; Wiedenmann B
    Verh Dtsch Ges Pathol; 1997; 81():157-61. PubMed ID: 9474867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptophysin and chromogranins/secretogranins--widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis.
    Wiedenmann B; Huttner WB
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 58(2):95-121. PubMed ID: 2575822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers for neuroendocrine differentiation.
    Bishop AE; Power RF; Polak JM
    Pathol Res Pract; 1988 Apr; 183(2):119-28. PubMed ID: 2968544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance.
    Hong SM; Kim MJ; Pi DY; Jo D; Yu E; Ro JY
    Hum Pathol; 2005 Jul; 36(7):732-40. PubMed ID: 16084941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine differentiation in primary Merkel cell carcinoma--possible prognostic significance.
    Koljonen V; Haglund C; Tukiainen E; Böhling T
    Anticancer Res; 2005; 25(2A):853-8. PubMed ID: 15868919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adrenocortical tumors with neuroendocrine differentiation].
    Kazantseva IA; Poliakova GA; Gurevich LG; Morozov IA; Bezuglova TV; Smirnov VB
    Arkh Patol; 2002; 64(5):8-13. PubMed ID: 12575533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary blastoma with neuroendocrine differentiation in cell morules resembling neuroepithelial bodies.
    Chejfec G; Cosnow I; Gould NS; Husain AN; Gould VE
    Histopathology; 1990 Oct; 17(4):353-8. PubMed ID: 2124206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic influence of neuroendocrine differentiation in breast cancer: results of a long-term follow-up study.
    van Krimpen C; Elferink A; Broodman CA; Hop WC; Pronk A; Menke M
    Breast; 2004 Aug; 13(4):329-33. PubMed ID: 15325669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptophysin expressed in the bronchopulmonary tract: neuroendocrine cells, neuroepithelial bodies, and neuroendocrine neoplasms.
    Lee I; Gould VE; Moll R; Wiedenmann B; Franke WW
    Differentiation; 1987; 34(2):115-25. PubMed ID: 2442053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
    Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
    Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
    Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
    Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
    Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
    Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptophysin. A widespread constituent of small neuroendocrine vesicles and a new tool in tumor diagnosis.
    Wiedenmann B
    Acta Oncol; 1991; 30(4):435-40. PubMed ID: 1649612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine differentiation in prostate cancer.
    Shariff AH; Ather MH
    Urology; 2006 Jul; 68(1):2-8. PubMed ID: 16844446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.